RAVI VIJ, MD

Leuprolide acetate (for depot suspension), 7.5 mg

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Biopsy and aspiration of bone marrow sample for diagnosis

Administration of chemotherapy into vein, 1 hour or less

Injection, octreotide, depot form for intramuscular injection, 1 mg

New patient office or other outpatient visit, 45-59 minutes

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

Administration of additional new drug or substance into vein, 1 hour or less

Established patient office or other outpatient visit, 30-39 minutes

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Infusion into a vein for hydration, 31-60 minutes

Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Administration of chemotherapy into vein, each additional hour

Injection, alteplase recombinant, 1 mg

Collection of blood sample from implanted device

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Established patient office or other outpatient visit, 20-29 minutes

Declotting of central venous tube

Injection of additional new drug or substance into vein

Infusion into a vein for hydration, each additional hour

Injection, pembrolizumab, 1 mg

Injection, zoledronic acid, 1 mg

Collection of blood sample from central venous tube

Injection, daratumumab, 10 mg and hyaluronidase-fihj

Injection, bortezomib, 0.1 mg

Injection of drug or substance under skin or into muscle

Injection, palonosetron hcl, 25 mcg

Injection, denosumab, 1 mg

Injection, paclitaxel protein-bound particles, 1 mg

Insertion of needle into vein for collection of blood sample

Infusion, normal saline solution , 1000 cc

Injection, diphenhydramine hcl, up to 50 mg

Injection, fluorouracil, 500 mg

Injection, carboplatin, 50 mg

Unclassified drugs

Injection, azacitidine, 1 mg

Injection, granisetron hydrochloride, 100 mcg

Injection, fosaprepitant, 1 mg

Injection, dexamethasone sodium phosphate, 1 mg